Skin manifestations of inhaled corticosteroids in COPD patients: Results from Lung Health Study II

Keyphrases

• Health Studies 100%
• Lung Health 100%
• Skin Manifestations 100%
• COPD Patients 100%
• Inhaled Corticosteroids 100%
• Bruise 100%
• Placebo 66%
• Bone Mineral Density 50%
• Inhaled Corticosteroid Therapy 50%
• Clinical Trials 33%
• Healing 33%
• Moderate to Severe 33%
• Adrenal Function 33%
• Inhaler 33%
• Sore 33%
• Easy Bruising 33%
• Randomized Placebo-controlled Trial 16%
• Older Men 16%
• Triamcinolone Acetonide 16%
• High Dose 16%
• Middle-aged 16%
• Smokers 16%
• Serial Measurements 16%
• Skin Changes 16%
• Systemic Effects 16%
• Increased Incidence 16%
• Elderly People 16%
• Systemic Toxicity 16%
• Ex-smokers 16%
• Systemic Complications 16%
• Skin Rash 16%
• Structured Questionnaire 16%
• Canister 16%
• Adrenal Suppression 16%
• Skin Healing 16%
• Cutaneous Manifestations 16%
• Inhaler Use 16%

Medicine and Dentistry

• Chronic Obstructive Pulmonary Disease 100%
• Skin Manifestation 100%
• Placebo 100%
• Skin Bruising 80%
• Bone Density 60%
• Clinical Trial 40%
• Smoking 40%
• Corticosteroid Therapy 40%
• Adrenal Function 40%
• Drug Megadose 20%
• middle age 20%
• Exanthem 20%
• Controlled Clinical Trial 20%
• Adrenal Suppression 20%
• Triamcinolone Acetonide 20%

Nursing and Health Professions

• Obstructive Lung Disease 100%
• Placebo 100%
• Skin Manifestation 100%
• Skin Bruising 80%
• Inhaler 60%
• Bone Density 60%
• Compliance 40%
• Corticosteroid Therapy 40%
• Rash 20%
• Drug Megadose 20%
• Adrenal Suppression 20%
• Triamcinolone Acetonide 20%